My view.
The company has forced off receivership and now can get on with business of producing. This could signal a bottom in the price and we could move up from here.
The company has been developing 2 companies not just one hence the higher overheads and we as shareholders will reap the benefits when all is up and running to capacity.
We are still making revenue and IO price is increasing.
Point to self: should have sold when resistance was broken at 16cents.Yes i am long term but would loved to have sat out the last 2 months of pain.
ADY needs to consolidate the register even without demerger as too much turnover is happening.
PT has more than most to lose if the company does not perform over the next two years.
- Forums
- ASX - By Stock
- points
My view.The company has forced off receivership and now can get...
Featured News
Add ADY (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.40M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 740867 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1366312 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 740867 | 0.006 |
8 | 4894566 | 0.005 |
4 | 1500000 | 0.004 |
1 | 700000 | 0.003 |
1 | 1000000 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1366312 | 1 |
0.008 | 2475934 | 3 |
0.009 | 156360 | 1 |
0.014 | 125000 | 1 |
0.016 | 500000 | 1 |
Last trade - 10.19am 13/11/2024 (20 minute delay) ? |
Featured News
ADY (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online